[go: up one dir, main page]

ES2101531T3 - Derivados de benzo(f)quinoxalinadiona, su preparacion y su utilizacion en medicamentos. - Google Patents

Derivados de benzo(f)quinoxalinadiona, su preparacion y su utilizacion en medicamentos.

Info

Publication number
ES2101531T3
ES2101531T3 ES94914315T ES94914315T ES2101531T3 ES 2101531 T3 ES2101531 T3 ES 2101531T3 ES 94914315 T ES94914315 T ES 94914315T ES 94914315 T ES94914315 T ES 94914315T ES 2101531 T3 ES2101531 T3 ES 2101531T3
Authority
ES
Spain
Prior art keywords
medicines
preparation
quinoxalinadiona
benzo
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94914315T
Other languages
English (en)
Inventor
Peter Holscher
Lechoslaw Turski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2101531T3 publication Critical patent/ES2101531T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

SE DESCRIBEN COMPUESTOS DE LA FORMULA (I), DONDE LOS SUSTITUYENTES R{SUP,1} HASTA R{SUP,4} SE DEFINEN COMO EN LA APLICACION, ASI COMO SU ELABORACION Y UTILIZACION EN MEDICAMENTOS.
ES94914315T 1993-04-28 1994-04-28 Derivados de benzo(f)quinoxalinadiona, su preparacion y su utilizacion en medicamentos. Expired - Lifetime ES2101531T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4314592A DE4314592A1 (de) 1993-04-28 1993-04-28 Benzo(f)chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln

Publications (1)

Publication Number Publication Date
ES2101531T3 true ES2101531T3 (es) 1997-07-01

Family

ID=6487059

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94914315T Expired - Lifetime ES2101531T3 (es) 1993-04-28 1994-04-28 Derivados de benzo(f)quinoxalinadiona, su preparacion y su utilizacion en medicamentos.

Country Status (23)

Country Link
US (1) US5710138A (es)
EP (1) EP0696289B1 (es)
JP (1) JPH08512289A (es)
KR (1) KR960701883A (es)
CN (1) CN1041935C (es)
AT (1) ATE150026T1 (es)
AU (1) AU683258B2 (es)
CA (1) CA2161426A1 (es)
CZ (1) CZ276395A3 (es)
DE (2) DE4314592A1 (es)
DK (1) DK0696289T3 (es)
ES (1) ES2101531T3 (es)
FI (1) FI955142A7 (es)
GR (1) GR3022867T3 (es)
HU (1) HUT72439A (es)
IL (1) IL109398A (es)
NO (1) NO305519B1 (es)
NZ (1) NZ265601A (es)
PL (1) PL174292B1 (es)
RU (1) RU2140421C1 (es)
SK (1) SK131795A3 (es)
WO (1) WO1994025470A1 (es)
ZA (1) ZA942971B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057304A (en) * 1992-10-26 2000-05-02 Schering Aktiengesellschaft Quinoxaline-phosphonic acid derivatives
NZ334891A (en) * 1996-10-24 2001-04-27 Novartis Ag Substituted aminoalkane phosphonic acids for treating block excitatory amino acid receptors related diseases
DE19728326A1 (de) * 1997-06-27 1999-01-07 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
CN113620890B (zh) * 2020-05-07 2024-06-28 普济生物科技（台州）有限公司 苯并喹喔啉酮化合物及其合成方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
DK716188D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
DK69790D0 (da) * 1990-03-16 1990-03-16 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling af anvendelse
DK73091D0 (da) * 1991-04-22 1991-04-22 Novo Nordisk As Quinoxalinforbindelser, deres fremstilling og anvendelse
PT101004B (pt) * 1991-10-26 1999-10-29 Schering Ag Derivados da quinoxalina, processo para a sua preparacao e composicoes farmaceuticas que os contem
DK31093D0 (es) * 1993-03-19 1993-03-19 Novo Nordisk As

Also Published As

Publication number Publication date
IL109398A (en) 1999-12-22
CN1122136A (zh) 1996-05-08
PL174292B1 (pl) 1998-07-31
GR3022867T3 (en) 1997-06-30
CN1041935C (zh) 1999-02-03
AU6675794A (en) 1994-11-21
HU9502647D0 (en) 1995-11-28
ZA942971B (en) 1995-01-19
AU683258B2 (en) 1997-11-06
EP0696289A1 (de) 1996-02-14
NO954316L (no) 1995-12-28
DK0696289T3 (da) 1997-09-22
EP0696289B1 (de) 1997-03-12
ATE150026T1 (de) 1997-03-15
NZ265601A (en) 1996-09-25
IL109398A0 (en) 1994-07-31
HUT72439A (en) 1996-04-29
DE4314592A1 (de) 1994-11-03
WO1994025470A1 (de) 1994-11-10
US5710138A (en) 1998-01-20
JPH08512289A (ja) 1996-12-24
KR960701883A (ko) 1996-03-28
CA2161426A1 (en) 1994-11-10
FI955142L (fi) 1995-10-27
FI955142A0 (fi) 1995-10-27
CZ276395A3 (en) 1996-02-14
NO305519B1 (no) 1999-06-14
NO954316D0 (no) 1995-10-27
PL311296A1 (en) 1996-02-05
FI955142A7 (fi) 1995-10-27
RU2140421C1 (ru) 1999-10-27
SK131795A3 (en) 1996-07-03
DE59402079D1 (de) 1997-04-17

Similar Documents

Publication Publication Date Title
ES2150989T3 (es) Nuevos derivados de quinoxalinadiona, su preparacion y empleo en medicamentos.
ES2148476T3 (es) Derivados de azabicicloalcano n-substituidos como neurolepticos asf.
ES2080739T3 (es) Nitro-compuestos insecticidamente activos.
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
ES2085876T3 (es) Derivado de bifenilmetano, su utilizacion y composiciones farmacologicas que contienen el mismo.
MX9102582A (es) Derivados de indol 3,7-disubstituidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES2186783T3 (es) Derivados de la dolastatina, su preparacion y uso.
FI954979A7 (fi) Kemoherkistävinä aineina käytettävät 10,11-metanodibentsosuberaanijohdannaiset
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
NZ233735A (en) Heterocyclic substituted aminophenol derivatives
SE8200171L (sv) 3-aminopropoxiaryl-derivat, framstellning derav och lekemedel innehallande dessa
ES2174298T3 (es) Derivados de aminotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2091310T3 (es) Nuevos derivados de la n-benzoil-prolina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DK0692484T3 (da) Benzothiadiazinderivat, fremgangsmåde til fremstilling deraf samt farmaceutiske sammensætninger indeholdende derivatet
IT8920929A0 (it) Nuovi derivati del r( ) 3 chinuclidinolo.
ES2154311T3 (es) Quinoxalinas, procedimiento para su preparacion y su utilizacion.
ES2160308T3 (es) Nuevos derivados amino-metil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2101531T3 (es) Derivados de benzo(f)quinoxalinadiona, su preparacion y su utilizacion en medicamentos.
ES2156212T3 (es) Derivados de azabicicloheptano n-substituidos como neurolepticos, etc.
DE69012619D1 (de) Bis(1-Hydrocarbyloxy-2,2,6,6-tetramethylpiperidin-4-yl)-amin-derivate und stabilisierte Zusammensetzungen.
ES2060944T3 (es) Derivados de 2,5,6,7-tetranor-4,8-inter-m-fenileno de pgi2 (prostaglandina i2).
ES2039211T3 (es) Nuevos n-glicosilamidoderivados, procedimientos para su obtencion y su empleo como medicamentos.
DE69431662D1 (de) Stabilisierte tablettenformulierung

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 696289

Country of ref document: ES